Pharma Articles
Renowned pharmaceutical firm executives and other experts from around the world write articles on current topics in the industry. The section of articles on the pharmaceutical sector focuses on contemporary and expanding challenges in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
Challenges and Compliance in Pharma HCP Communication
One of the most controlled sectors in the world today pharmaceutical companies must interact with healthcare professionals HCPs communication between these two stakeholders being very necessary but highly regulated Pharma HCP communication is the most common way in which a company communicates with...Modern Mental Health Medications: A Guide to Antidepressants, Anxiety Drugs, and New Treatments
The treatment of mental health disorders has evolved dramatically over the past few decades Today mental health medications are more targeted effective and better tolerated than ever before The development of modern mental health drugs reflects an increased understanding of brain chemistry and the m...Role of Medical Affairs in HCP Engagement: Effective Strategies and Tools for Success
Medical Affairs acts as the critical linking factor in the current day evidencebased healthcare environment between the pharmaceutical industry and the clinical community The Medical Affairs strategy does not pass through delivering medical information anymore it has already become an active model o...Omnichannel Pharma Marketing for HCP Engagement
With the pharmaceutical industry now being very competitive it has been observed that modern brands have put a lot of focus on meaningful HCP engagement plans in order to create a personal and longterm relationship with healthcare professionals The old system of sales visits and conferences is being...Top Obesity and Diabetes Medications Transforming U.S. Pharma Market
The US healthcare system is at a turning point as the dual epidemics of obesity and type diabetes drive demand for advanced treatments More than of American adults are obese while over million people live with diabetes These conditions are not only straining public health but also reshaping the p...Best Practices for Pharma HCP Engagement: Insights, Challenges, and Opportunities
Pharma HCP engagement is the act through which pharmaceutical firms engage communicate and collaborate with healthcare professionals HCPs which includes physicians specialists pharmacists and nurses These relationships extend beyond standard selling conferences to incorporate scientific education cl...Twin-Screw Melt Granulation: A Solvent-Free, Single-Step Solution for Enhancing Drug Solubility
Over the last few decades the pharmaceutical industry has been facing persistent challenges in delivering poorly soluble drug candidates Every pipeline has promising drug candidates that are stalled by the solubility limitations In recent years the twinscrew melt granulation TSMG approach has been m...Patient-Centric Pharma: How to Engage, Educate, and Empower Patients Effectively
The pharmaceutical sector is experiencing a radical change with the focus now being on patientfocused pharma strategies instead of productbased approaches Patients are not the passive consumers of healthcare anymore they are informed participants in the healthcare business environment and seek to ac...Green Chemistry in Pharma: Sustainable Drug Manufacturing
The pharmaceutical sector is at crossroads On the one hand it is the huge task of creating lifesaving drugs and on the other an unquestionably large pressure on minimizing the harm that drug production can cause to the environment This is where green chemistry in the pharmaceutical sector comes into...How U.S. Drug Pricing and Tariffs Are Reshaping Big Pharma Profits in 2025
The United States pharmaceutical sector is experiencing one of the most dramatic changes of the recent decades As new US drug pricing reforms in and changing pharmaceutical tariffs redefine the financial health of Big Pharma it is being transformed Policies to lower the cost of medicine to patients...
